An Australian study suggests women and men with diabetes have lower life expectancy and more years of disability than nondiabetics; women with diabetes spend the most time living with disability. Medscape Medical News
Combination therapy may offer better outcomes for patients with retinoblastoma
Researchers at The Saban Research Institute of Children’s Hospital Los Angeles (CHLA) have demonstrated that targeting survivin — a protein that inhibits apoptosis or cell death — enhances the…
Largest eye study among Chinese Americans identifying more effective ways to prevent and treat blinding eye diseases for this racial group
The University of Southern California (USC) Roski Eye Institute researchers and clinicians published the results of the National Eye Institute-funded “Chinese American Eye Study (CHES),” the…
Uncategorized
McKesson Patient Relationship Solutions a Finalist for eyeforpharma Philadelphia Awards 2016
SCOTTSDALE, Ariz.–(BUSINESS WIRE)–McKesson Patient Relationship Solutions (MPRS) has been named a finalist in the eyeforpharma Philadelphia Awards 2016.
Survivin inhibitor with chemotherapy provides therapeutic advantage for Rb cells, tumors
Researchers at The Saban Research Institute of Children’s Hospital Los Angeles (CHLA) have demonstrated that targeting survivin – a protein that inhibits apoptosis or cell death – enhances the effectiveness of chemotherapy in cells and mouse models of …
Uncategorized
Bowman’s layer transplantation may be safer surgery for patients with advanced keratoconus
For most eyes with advanced keratoconus, penetrating keratoplasty is a bad option. It permanently weakens the cornea, precipitates cataracts, promotes glaucoma, provides an often uneven and unstable refractive surface, presents the constant risk of allograft reaction and graft rejection, and — perhaps worst of all — produces many unhappy patients, particularly if the surgery was elective and not emergently required.Nevertheless, PK so far remains the most common surgical treatment worldwide for patients with advanced keratoconus. And while alternatives to conventional PK have emerged, including deep anterior lamellar keratoplasty and new femtosecond technology for creating and shaping the donor and recipient surfaces, for the most part, these innovations have merely mitigated the impact of some of the above problems without actually solving any of them. Meanwhile, ultraviolet corneal cross-linking and intracorneal ring segments have arrived but, presently, are still limited in their application exclusively to patients with mild to moderate stage disease. What has been sorely lacking is a new treatment option for patients with advanced keratoconus that is effective and, at the same time, free from the considerable difficulties that both PK and DALK frequently entail.